ANI Pharmaceuticals's market cap is currently $1.25B. The company's EPS TTM is $-0.541; its P/E ratio is ―; ANI Pharmaceuticals is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is $1.44. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 486.82M	$ 316.38M	$ 216.14M	$ 208.47M	$ 206.55M
Gross Profit	$ 305.30M	$ 177.60M	$ 115.53M	$ 121.32M	$ 143.39M
Operating Income	$ 46.97M	$ -25.06M	$ -32.51M	$ -16.06M	$ 16.35M
EBITDA	$ 106.60M	$ 48.07M	$ -1.68M	$ 29.07M	$ 60.73M
Net Income	$ 18.78M	$ -47.90M	$ -42.60M	$ -22.55M	$ 6.09M
Balance Sheet
Cash & Short-Term Investments	$ 221.12M	$ 48.23M	$ 100.30M	$ 7.86M	$ 62.33M
Total Assets	$ 904.42M	$ 760.09M	$ 771.60M	$ 461.19M	$ 456.79M
Total Debt	$ 285.67M	$ 286.52M	$ 287.37M	$ 185.69M	$ 185.75M
Net Debt	$ 64.55M	$ 238.29M	$ 187.07M	$ 177.82M	$ 123.42M
Total Liabilities	$ 446.82M	$ 421.55M	$ 412.86M	$ 265.49M	$ 244.00M
Stockholders' Equity	$ 457.60M	$ 338.54M	$ 358.74M	$ 195.70M	$ 212.79M
Cash Flow
Free Cash Flow	$ 100.45M	$ -47.66M	$ -20.32M	$ -53.05M	$ 18.08M
Operating Cash Flow	$ 118.96M	$ -31.20M	$ 3.32M	$ 15.27M	$ 45.63M
Investing Cash Flow	$ -18.51M	$ -15.74M	$ -105.48M	$ -68.32M	$ -27.55M
Financing Cash Flow	$ 67.44M	$ -5.13M	$ 194.59M	$ -1.44M	$ 1.25M

Currency in USD

ANI Pharmaceuticals Earnings and Revenue History

Income Statement >

ANI Pharmaceuticals Debt to Assets

Balance Sheet >

ANI Pharmaceuticals Cash Flow

Cash Flow >

ANI Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing